UPDATE 1-BioMarin autoimmune disease drug gets orphan status
Reuters
Nov 30 (Reuters) – BioMarin Pharmaceutical Inc (BMRN.O) said its experimental treatment for a rare autoimmune disease received orphan drug status from the
biomarin treatment gets special FDA statusCNBC
BioMarin's Autoimmune Disease Drug Gets Orphan Drug Status – UpdateRTT News
FDA Grants Orphan Drug Designation for 3,4-DAP for LEMSPR Newswire (press release)

all 27 news articles »

UPDATE 1-BioMarin autoimmune disease drug gets orphan status – Reuters

Share and Enjoy:
  • Print
  • Digg
  • Sphinn
  • del.icio.us
  • Facebook
  • Mixx
  • Google Bookmarks

Random Posts

Related posts:

  1. Endo Pharmaceuticals Gives Update on Regulatory Status of FORTESTA(TM) – Reuters
  2. Endo Pharmaceuticals Gives Update on Regulatory Status of … – Reuters
  3. BioMarin 3Q profit jumps improved drug sales – Forbes